IL13Rα2 D1
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


IL13Rα2 D1
Description:
IL13Rα2 D1 is an effective IL-13/IL13Rα2 signaling axis inhibitor. IL13Rα2 D1 can inhibit IL-13-induced cell adhesion, migration, invasion, and proliferation. IL13Rα2 D1 can inhibit FAK, Src, AKT, ERK1/2 phosphorylation, and MMP expression. IL13Rα2 D1 can be used for research on cancers such as colorectal cancer[1].UNSPSC:
12352209Target:
Akt; ERK; FAK; Interleukin Related; MMP; SrcRelated Pathways:
Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK; Stem Cell/WntField of Research:
CancerSmiles:
O=C (N[C@@H] (CO) C (N[C@@H] (CCC (O) =O) C (N[C@@H] ([C@H] (O) C) C (N[C@@H] (CC1=CNC2=CC=CC=C12) C (N[C@@H] (CCCCN) C (N[C@@H] ([C@H] (O) C) C (N[C@@H] ([C@@H] (C) CC) C (N[C@@H] ([C@@H] (C) CC) C (N[C@@H] ([C@H] (O) C) C (N[C@@H] (CCCCN) C (N[C@@H] (CC (N) =O) C (O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) CNMolecular Formula:
C61H100N16O20Molecular Weight:
1377.54References & Citations:
[1]Bartolomé RA, et al. An IL13Rα2 peptide exhibits therapeutic activity against metastatic colorectal cancer. Br J Cancer. 2018 Oct;119 (8) :940-949.Shipping Conditions:
Room temperatureScientific Category:
PeptidesClinical Information:
No Development ReportedIsoform:
IL-13CAS Number:
2319573-67-4
